An earlier AD study from our Memory Clinic using cluster analysis reported worse cognitive short-term response to ChEI treatment in the cluster that included patients with very high levels of P-tau and T-tau, i.e., a more aggressive disease [24]. This evidence concerns the gene MAPT and Alzheimer disease.